Tune Therapeutics

Durham, NC · Founded 2020 · Privately Held (backing)

Developer of an epigenetic programming platform designed to create new pathways for the treatment of disease. Tune Therapeutics is based in Durham, NC and was founded in 2020. Its last reported valuation was $340 million in Jan 2025. It has raised $222 million.

Last reported valuation

$340.0M

Oct 2026

Priced at

—

Total raised

$222.4M

Last round

—

How much has Tune Therapeutics raised?

$222.4Macross 0 recorded rounds

Free account

More of Tune Therapeutics with a free account

·The complete investor list: 15 names
·Watch Tune Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Tune Therapeutics investors

15 investors are on record for Tune Therapeutics, including New Enterprise Associates, Emerson Collective, Duke Capital Partners and Hatteras Venture Partners.

For fundraisers

Raising for a company like Tune Therapeutics?

15 investors have backed Tune Therapeutics.

See all 15 investors →

Frequently asked about Tune Therapeutics

How much has Tune Therapeutics raised?: Tune Therapeutics has raised $222.4M in total across 0 recorded funding rounds.